Correlation Between Zura Bio and AbbVie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zura Bio and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and AbbVie Inc, you can compare the effects of market volatilities on Zura Bio and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and AbbVie.

Diversification Opportunities for Zura Bio and AbbVie

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Zura and AbbVie is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Zura Bio i.e., Zura Bio and AbbVie go up and down completely randomly.

Pair Corralation between Zura Bio and AbbVie

Given the investment horizon of 90 days Zura Bio Limited is expected to generate 5.43 times more return on investment than AbbVie. However, Zura Bio is 5.43 times more volatile than AbbVie Inc. It trades about 0.08 of its potential returns per unit of risk. AbbVie Inc is currently generating about 0.09 per unit of risk. If you would invest  126.00  in Zura Bio Limited on May 8, 2025 and sell it today you would earn a total of  31.00  from holding Zura Bio Limited or generate 24.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Zura Bio Limited  vs.  AbbVie Inc

 Performance 
       Timeline  
Zura Bio Limited 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Zura Bio Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Zura Bio sustained solid returns over the last few months and may actually be approaching a breakup point.
AbbVie Inc 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in AbbVie Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting fundamental drivers, AbbVie may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Zura Bio and AbbVie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zura Bio and AbbVie

The main advantage of trading using opposite Zura Bio and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.
The idea behind Zura Bio Limited and AbbVie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm